LXRX FY 2021 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$298,000-98.8% YoY

Gross Profit

-$55M-18371.8% margin

Operating Income

-$87M-29224.8% margin

Net Income

-$88M-29449.0% margin

EPS (Diluted)

$-0.61

Cash Flow

Operating Cash Flow

-$87M

Free Cash Flow

-$88M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$137M

Total Liabilities

$23M

Stockholders' Equity

$114M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$298,000	$24M	-98.8%
Gross Profit	-$55M	$22M	-348.1%
Operating Income	-$87M	-$48M	-82.2%
Net Income	-$88M	-$59M	-49.8%